サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788318

大動脈の蘇生的血管内バルーン閉塞術の世界市場

Resuscitative Endovascular Balloon Occlusion of the Aorta

出版日
ページ情報
英文 109 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
大動脈の蘇生的血管内バルーン閉塞術の世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 109 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

大動脈の蘇生的血管内バルーン閉塞術の世界市場は2030年までに3,720万米ドルに達する見込み

2024年に1,250万米ドルと推定される大動脈の蘇生的血管内バルーン閉塞術の世界市場は、2030年には3,720万米ドルに達すると予測され、分析期間2024-2030年のCAGRは20.0%で成長すると予測されます。本レポートで分析したセグメントの1つである心停止は、CAGR18.3％を記録し、分析期間終了までに2,170万米ドルに達すると予測されます。大動脈閉塞症セグメントの成長率は、分析期間でCAGR 23.0％と推定されます。

米国市場は330万米ドルと推定、中国はCAGR19.0％で成長予測

米国の大動脈の蘇生的血管内バルーン閉塞術市場は、2024年に330万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに570万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは19.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ18.1％と17.5％と予測されています。欧州では、ドイツがCAGR約14.9%で成長すると予測されています。

世界の大動脈の蘇生的血管内バルーン閉塞術市場- 主要動向と促進要因のまとめ

大動脈の蘇生的血管内バルーン閉塞術（REBOA）が外傷治療で広く採用されている理由とは？

大動脈の蘇生的血管内バルーン閉塞術（REBOA）は、重度の腹部、骨盤、下肢損傷による出血性ショックを経験した外傷患者の救命介入として登場しました。従来、このような症例で出血がコントロールできない場合は、直ちに開腹手術が行われてきたが、REBOAは、一時的に出血をコントロールし、確定的な外科治療が行えるまで患者を安定させることで、生存率を向上させる低侵襲の代替手段を提供します。交通事故、戦場での負傷、産業事故による外傷の発生率の増加が、救急医療や軍事医療におけるREBOA手技の需要を押し上げています。さらに、バスキュラーアクセス技術の進歩により、この手技はより利用しやすくなり、外傷センターや病院前医療での採用が増加しています。

技術革新はどのようにREBOAの効率性と安全性を高めているのか？

カテーテルを用いたインターベンションと血管内治療技術の革新は、REBOA手技の有効性と安全性を著しく向上させました。より小型で薄型のバルーンカテーテルの開発により、血管アクセスに伴う合併症や閉塞時間の延長が減少しました。さらに、リアルタイムの画像ガイダンスと圧力モニタリングシステムにより、より正確なバルーンの留置と膨張が可能となり、虚血傷害のリスクが最小限に抑えられています。また、ワイヤレスモニター機能を備えた自動REBOAシステムも研究されており、臨床医が遠隔操作で閉塞レベルを調整し、灌流制御を最適化できるようになっています。このような技術的進歩により、REBOAは外傷管理のより現実的で安全な選択肢となりつつあり、その臨床応用は従来の救急環境以外にも広がっています。

REBOA市場の拡大を牽引する市場動向とは？

外傷治療のインフラ整備が重視されるようになったことで、民間と軍両方のヘルスケア環境でREBOAの採用が増加しています。救急車や航空医療搬送ユニットを含む病院前救急サービスへのREBOAの統合は、その範囲をさらに拡大しています。さらに、医療機関はREBOAトレーニングプログラムに投資し、外傷外科医、救急医、クリティカルケアチームにこの手技を効果的に行うために必要なスキルを身につけさせようとしています。ハイブリッド手術室や血管内外傷管理プロトコルの台頭も、三次医療センターにおけるREBOAの幅広い採用を促進しています。さらに、外傷による死亡率の減少を目的とした政府の資金援助や研究イニシアティブが市場の成長を支えています。

REBOA市場の主な成長促進要因は？

世界のREBOA市場の成長を牽引しているのは、外傷関連死亡者数の増加、血管内バルーン閉塞技術の進歩、救急外傷治療インフラの拡大です。特に軍や民間の外傷センターでは、低侵襲の救命処置が採用されており、需要がさらに加速しています。さらに、REBOA技術を最適化し、産後出血などの非外傷症状への応用を拡大するための継続的な臨床研究が、市場の可能性を広げています。AIを搭載したモニタリングシステムとロボット支援血管処置の統合も、REBOAの精度と安全性を高め、市場拡大に拍車をかけると予想されます。ヘルスケアシステムが外傷患者への迅速な介入戦略を優先する中、REBOA市場は救急医療分野に革命をもたらし、大幅な成長が見込まれています。

セグメント

エンドユース（心停止、大動脈閉塞、戦術的戦闘傷病者ケア）

調査対象企業の例

  • Abbott Laboratories
  • Acandis GmbH
  • AngioDynamics, Inc.
  • Asahi Kasei Corporation
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BVM Medical Limited
  • Cardinal Health, Inc.
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Emergency Scientific, LLC
  • Front Line Medical Technologies
  • Johnson & Johnson
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Mermaid Medical Group
  • MicroPort Scientific Corporation
  • Oscor Inc.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32807

Global Resuscitative Endovascular Balloon Occlusion of the Aorta Market to Reach US$37.2 Million by 2030

The global market for Resuscitative Endovascular Balloon Occlusion of the Aorta estimated at US$12.5 Million in the year 2024, is expected to reach US$37.2 Million by 2030, growing at a CAGR of 20.0% over the analysis period 2024-2030. Cardiac Arrest, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$21.7 Million by the end of the analysis period. Growth in the Aortic Occlusion segment is estimated at 23.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Million While China is Forecast to Grow at 19.0% CAGR

The Resuscitative Endovascular Balloon Occlusion of the Aorta market in the U.S. is estimated at US$3.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.7 Million by the year 2030 trailing a CAGR of 19.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.1% and 17.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.9% CAGR.

Global Resuscitative Endovascular Balloon Occlusion of the Aorta Market - Key Trends & Drivers Summarized

Why Is Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Gaining Widespread Adoption in Trauma Care?

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has emerged as a life-saving intervention for trauma patients experiencing hemorrhagic shock due to severe abdominal, pelvic, or lower extremity injuries. Traditionally, uncontrolled bleeding in such cases has been managed through immediate open surgery, but REBOA offers a minimally invasive alternative that improves survival rates by temporarily controlling hemorrhage and stabilizing patients until definitive surgical treatment can be performed. The increasing incidence of traumatic injuries from road accidents, battlefield injuries, and industrial accidents has driven the demand for REBOA procedures in emergency and military medicine. Additionally, advancements in vascular access technology have made the procedure more accessible, increasing its adoption across trauma centers and pre-hospital care settings.

How Are Technological Innovations Enhancing the Efficiency and Safety of REBOA?

Innovations in catheter-based interventions and endovascular technology have significantly improved the efficacy and safety of REBOA procedures. The development of smaller, lower-profile balloon catheters has reduced complications associated with vascular access and prolonged occlusion times. Additionally, real-time imaging guidance and pressure monitoring systems are enabling more precise placement and inflation of the balloon, minimizing the risk of ischemic injury. Automated REBOA systems with wireless monitoring capabilities are also being explored, allowing clinicians to remotely adjust occlusion levels and optimize perfusion control. These technological advancements are making REBOA a more viable and safer option for trauma management, expanding its clinical applications beyond traditional emergency settings.

What Market Trends Are Driving the Expansion of the REBOA Market?

The growing emphasis on improving trauma care infrastructure has led to increased adoption of REBOA in both civilian and military healthcare settings. The integration of REBOA into pre-hospital emergency services, including ambulance and air-medical transport units, is further expanding its reach. Additionally, medical institutions are investing in REBOA training programs to equip trauma surgeons, emergency physicians, and critical care teams with the necessary skills to perform the procedure effectively. The rise of hybrid operating rooms and endovascular trauma management protocols has also facilitated the wider adoption of REBOA in tertiary care centers. Moreover, government funding and research initiatives aimed at reducing mortality from traumatic injuries are supporting the market's growth.

What Are the Key Growth Drivers of the REBOA Market?

The growth in the global REBOA market is driven by increasing trauma-related fatalities, advancements in endovascular balloon occlusion technology, and the expansion of emergency trauma care infrastructure. The adoption of minimally invasive life-saving procedures, particularly in military and civilian trauma centers, has further accelerated demand. Additionally, ongoing clinical research into optimizing REBOA techniques and expanding its applications in non-trauma conditions, such as postpartum hemorrhage, is broadening its market potential. The integration of AI-powered monitoring systems and robotic-assisted vascular procedures is also expected to enhance the precision and safety of REBOA, fueling market expansion. As healthcare systems prioritize rapid intervention strategies for trauma patients, the REBOA market is poised for substantial growth, revolutionizing the field of emergency medicine.

SCOPE OF STUDY:

The report analyzes the Resuscitative Endovascular Balloon Occlusion of the Aorta market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Acandis GmbH
  • AngioDynamics, Inc.
  • Asahi Kasei Corporation
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BVM Medical Limited
  • Cardinal Health, Inc.
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Emergency Scientific, LLC
  • Front Line Medical Technologies
  • Johnson & Johnson
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Mermaid Medical Group
  • MicroPort Scientific Corporation
  • Oscor Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Resuscitative Endovascular Balloon Occlusion of the Aorta - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Traumatic Hemorrhage and Non-Compressible Bleeding Conditions Drives REBOA Adoption
    • Increased Recognition of REBOA as a Life-Saving Pre-Hospital and Emergency Room Intervention Spurs Clinical Uptake
    • Technological Advancements in Balloon Catheter Design Enhance Ease of Deployment and Procedural Speed
    • Expansion of Trauma and Acute Care Surgery Programs Throws the Spotlight on Endovascular Resuscitation Devices
    • Surge in Combat and Military Applications Strengthens Business Case for REBOA in Battlefield Medicine
    • Regulatory Approvals for Low-Profile and Partial Occlusion Devices Expand Indication Spectrum
    • Growth in Emergency Medicine Residency Training Supports Familiarity and Usage of REBOA Systems
    • Integration of REBOA in Trauma Protocols and ATLS Guidelines Drives Hospital Adoption Rates
    • Increased Utilization in Obstetric Hemorrhage and Ruptured Aneurysm Cases Expands Off-Label Applications
    • Development of Zone-Specific Occlusion Strategies Enhances Targeted Hemodynamic Stabilization
    • Partnerships Between Device Manufacturers and Trauma Centers Accelerate Product Validation and Usage
    • Surging Demand for Hemorrhage Control in Civilian Mass Casualty Incidents Fuels Device Availability
    • Adoption of Portable and Ultrasound-Guided REBOA Techniques Expands Pre-Hospital Intervention Capabilities
    • OEM Investment in Simulation-Based Training Programs Promotes Safe Implementation Across Institutions
    • Rising Emphasis on Damage Control Resuscitation Supports Complementary Role of REBOA With Surgical Interventions
    • Improved Data From Prospective Trials Strengthens Clinical Confidence and Inclusion in Guidelines
    • Use of REBOA in Hybrid Operating Rooms and Angio Suites Increases Workflow Integration
    • Focus on Reducing Time-to-Intervention and Transport-Related Mortality Drives REBOA Training Among Paramedics
    • Global Expansion of Advanced Trauma Systems Opens Market for REBOA in Developing Countries
    • Adoption of Balloon Occlusion Techniques in Non-Traumatic Hemorrhagic Shock Supports Expanded Utility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Resuscitative Endovascular Balloon Occlusion of the Aorta Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Arrest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cardiac Arrest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Aortic Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Aortic Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Tactical Combat Casualty Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Tactical Combat Casualty Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 10: USA Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 11: USA 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • CANADA
    • TABLE 12: Canada Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 13: Canada 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • JAPAN
    • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 14: Japan Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Japan 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • CHINA
    • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 16: China Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 17: China 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • EUROPE
    • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 18: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • FRANCE
    • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 22: France Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 23: France 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • GERMANY
    • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 24: Germany Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Germany 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • ITALY
    • TABLE 26: Italy Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Italy 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • UNITED KINGDOM
    • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 28: UK Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: UK 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 30: Rest of Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Rest of Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 32: Asia-Pacific Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Asia-Pacific 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 34: Rest of World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Rest of World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030

IV. COMPETITION